Archive: 2016

The First Large-Scale Precision Medicine Trial?

The Pancreatic Cancer Action Network has launched Precision Promise, which it calls, "the first large-scale precision medicine trial that will put the patient at the center of every decision." Read More

Get The Return You Need On Your mHealth Investment

You just decided to invest a significant portion of your innovation budget to power your clinical trial with new mobile health technology. Now what? Read More

Cancer Research UK Bridges Academia-Industry Gap, Free Of Commercial Risk

We'll discuss the challenges, opportunities and value that a patient-centric model presents for drug development. Read More

Medical Coding Plays Vital Role In Clinical Trial Speed

Imagine that you are the director of clinical systems at a life science company. Your goal is to ensure that the clinical trial succeeds. Read More

Risk-based Monitoring: People, Process & Systems In Motion

Much like driving a car on new roads, you don’t necessarily know what is around the next bend, so you must constantly monitor your surroundings. Read More

Is Machine Learning the Next Big Thing in Healthcare? (Part 1)

What are the latest trends in machine learning and how will it impact healthcare in the near future? Read More

Is Machine Learning the Next Big Thing in Healthcare? (Part 2)

What are the latest trends in machine learning and how will it impact healthcare in the near future? Read More

Time for Pharma to Catch Up With the FDA

Pharma's sentiment that the federal government’s policies perpetually lag behind innovations pioneered by the private sector has resulted in a vicious cycle of stagnated progress. Read More

Forget Big Data — Let's Talk Smart Data

There were two interesting posts this past week from Bernard Marr at Forbes and Pam Baker at FierceBigData on how big data will evolve and the predicted impacts on businesses. Read More

Pharma Is Long Due for a Disruption

Tech has already disrupted a number of industries such as music, books, retail, data storage, etc. Read More